Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Veronika Bachanova Muneer H Abidi Anna Sureda Patrick Stiff Auayporn Nademanee Craig H Moskowitz Edward Agura Simonetta Viviani John W Sweetenham Jerzy Hołowiecki Jan Walewski Tamás Masszi |
| Publication date | September 28, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |